miRNAs in the Pathogenesis of Systemic Lupus Erythematosus
AbstractMicroRNAs (miRNAs) were first discovered as regulatory RNAs that controlled the timing of the larval development of Caenorhabditis elegans. Since then, nearly 30,000 mature miRNA products have been found in many species, including plants, warms, flies and mammals. Currently, miRNAs are well established as endogenous small (~22 nt) noncoding RNAs, which have functions in regulating mRNA stability and translation. Owing to intensive investigations during the last decade, miRNAs were found to play essential roles in regulating many physiological and pathological processes. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by elevated autoantibodies against nuclear antigens and excessive inflammatory responses affecting multiple organs. Although efforts were taken and theories were produced to elucidate the pathogenesis of SLE, we still lack sufficient knowledge about the disease for developing effective therapies for lupus patients. Recent advances indicate that miRNAs are involved in the development of SLE, which gives us new insights into the pathogenesis of SLE and might lead to the finding of new therapeutic targets. Here, we will review recent discoveries about how miRNAs are involved in the pathogenesis of SLE and how it can promote the development of new therapy. View Full-Text
Share & Cite This Article
Qu, B.; Shen, N. miRNAs in the Pathogenesis of Systemic Lupus Erythematosus. Int. J. Mol. Sci. 2015, 16, 9557-9572.
Qu B, Shen N. miRNAs in the Pathogenesis of Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 2015; 16(5):9557-9572.Chicago/Turabian Style
Qu, Bo; Shen, Nan. 2015. "miRNAs in the Pathogenesis of Systemic Lupus Erythematosus." Int. J. Mol. Sci. 16, no. 5: 9557-9572.